National Express in double contract win
Transport company National Express Group has cheered investors with news of a contract wins in America and Spain.
Transport company National Express Group has cheered investors with news of a contract wins in America and Spain.
The firm's North American transit business has scored a new transit contract, which will begin on December 1st across the Piedmont 'Triad', North Carolina. The contact is worth around $12m of revenue over an initial period of two years, with the option of a further three.
Under the deal, the company will manage and operate 42 vehicles, seven days a week. Thirteen express and shuttle routes will run in and between the three cities of the Piedmont Triad, and are expected to carry 500,000 passengers a year.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
The group's Spanish business, ALSA, has also won the tender to provide bus services in Guadalajara. The contract, which is up to 12 years in length, will generate revenue of up to €77m and begins in mid-2013. ALSA will operate a fleet of 27 buses in Guadalajara carrying an estimated 3.7m passengers a year.
As part of the deal it will invest around €7m to help deliver hi-tech vehicles with on-board Wi-Fi and real-time information systems on bus stop screens.
Dean Finch, Group Chief Executive of National Express, said: "We are delighted with both of these contract wins. They demonstrate the attractiveness to local authorities of our market-leading and value-for-money services. Growth in our North American transit and Spanish urban businesses are important parts of our strategy. We look forward to serving the people of Guadalajara and Piedmont for many years to come."
The share price rose 5.17% to 173p by 14:45.
NR
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
-
GSK share price surges after $2.2bn Zantac drug settlement
GSK has settled lawsuits in the US that alleged the drugmaker’s now-discontinued heartburn drug Zantac triggered cancer
By Chris Newlands Published
-
Will the Autumn Budget impact investment markets?
Keir Starmer has warned the Autumn Budget will be “painful”. Will it impact investment markets and should you tweak your portfolio before 30 October?
By Katie Williams Published